# Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men

> **NCT00221052** · NA · COMPLETED · sponsor: **TNO** · enrollment: 20 (—)

## Conditions studied

- Overweight
- Obesity
- Inflammation

## Interventions

- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT00221052
- **Lead sponsor:** TNO
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221052, "Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00221052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*